NCT01404013 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Status UNKNOWN Phase PHASE4
NCT01402986 A Safety and Efficacy Study of Tralokinumab in Adults With Asthma Status COMPLETED Phase PHASE2
NCT01400906 Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics. Status COMPLETED Phase PHASE2
NCT01400217 Qvar Versus Clenil, a General Practice Research Database Study Status COMPLETED Phase N/A
NCT01397760 Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma Status UNKNOWN Phase N/A
NCT01397201 Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS) Status TERMINATED Phase PHASE2
NCT01397162 Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy Status TERMINATED Phase PHASE2
NCT01396278 Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS). Status TERMINATED Phase PHASE2
NCT01395589 Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations. Status COMPLETED Phase PHASE1
NCT01395485 Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma Status WITHDRAWN Phase PHASE1
NCT01393340 Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma Status COMPLETED Phase PHASE2
NCT01392859 Characterization of the Role of Histamine in Children With Asthma Status COMPLETED Phase PHASE2/PHASE3
NCT01386996 Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Status COMPLETED Phase PHASE1
NCT01385306 Noninvasive Neurostimulation of the Vagus Nerve for the Relief of Acute Bronchoconstriction Due to Asthma Status TERMINATED Phase NA
NCT01383499 A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma Status COMPLETED Phase PHASE2